A mitochondrial-targeted ubiquinone modulates muscle lipid profile and improves mitochondrial respiration in obesogenic diet-fed rats

British Journal of Nutrition

Volumn 115, Issue 7, 2016, Pages 1155-1166

  Coudray, Charles ^a   Fouret, Gilles ^a   Lambert, Karen ^b   Ferreri, Carla ^c   Rieusset, Jennifer ^d   Blachnio Zabielska, Agnieszka ^e   Lecomte, Jérôme ^f   Ebabe Elle, Raymond ^b   Badia, Eric ^b   Murphy, Michael P ^g   Feillet Coudray, Christine ^a  

^a University of Montpellier   (France)

^b UNIVERSITY OF MONTPELLIER   (France)

^c Istituto per la Sintesi Organica e la Fotoreattività   (Italy)

^d CarMeN   (France)

^e MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^f MONTPELLIER SUPAGRO   (France)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Fatty acids; High fat diet; Metabolic syndrome; Mitochondria; MitoQ; Muscle; Phospholipids

Indexed keywords

CERAMIDE; CYTOCHROME C OXIDASE; DIACYLGLYCEROL; FATTY ACID; INTERLEUKIN 6; MITOCHONDRIAL PROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SPHINGOMYELIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE; LIPID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HEPATOMEGALY; LIPID ANALYSIS; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; FATTY ACIDS; GLUCOSE INTOLERANCE; LIPID METABOLISM; LIPIDS; LIVER; MALE; METABOLIC SYNDROME X; MITOCHONDRIA; MUSCLE, SKELETAL; OBESITY; ORGAN SIZE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; UBIQUINONE; WEIGHT GAIN;

EID: 84960808721     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515005528     Document Type: Article

References (57)

1. Johnson RJ, Stenvinkel P, Martin SL, et al. (2013) Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) 21, 659-664.
2. Mendoza JA, Drewnowski A & Christakis DA (2007) Dietary energy density is associated with obesity and the metabolic syndrome in U. S. adults. Diabetes Care 30, 974-979.
3. Hegarty BD, Furler SM, Ye J, et al. (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178, 373-383.
4. Boren J, Taskinen MR, Olofsson SO, et al. (2013) Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 274, 25-40.
5. Koh EH, Lee WJ, Kim MS, et al. (2005) Intracellular fatty acid metabolism in skeletal muscle and insulin resistance. Curr Diabetes Rev 1, 331-336.
6. Koves TR, Ussher JR, Noland RC, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7, 45-56.
7. Rogge MM (2009) The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs 10, 356-373.
8. Randle PJ, Garland PB, Hales CN, et al. (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
9. Timmers S, Schrauwen P & de Vogel J (2008) Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 94, 242-251.
10. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, et al. (2010) Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 1801, 266-271.
11. Hage Hassan R, Bourron O & Hajduch E (2014) Defect of insulin signal in peripheral tissues: important role of ceramide. World J Diabetes 5, 244-257.
12. Montgomery MK & Turner N (2015) Mitochondrial dysfunction and insulin resistance: an update. Endocr Connect 4, R1-R15.
13. Mao G, Kraus GA, Kim I, et al. (2010) A mitochondria-targeted vitamin E derivative decreases hepatic oxidative stress and inhibits fat deposition in mice. J Nutr 140, 1425-1431.
14. Smith RA, Hartley RC & Murphy MP (2011) Mitochondriatargeted small molecule therapeutics and probes. Antioxid Redox Signal 15, 3021-3038.
15. Smith RA, Hartley RC, Cocheme HM, et al. (2012) Mitochondrial pharmacology. Trends Pharmacol Sci 33, 341-352.
16. Tauskela JS (2007) MitoQ-a mitochondria-targeted antioxidant. IDrugs 10, 399-412.
17. Smith RA & Murphy MP (2011) Mitochondria-targeted antioxidants as therapies. Discov Med 11, 106-114.
18. Gane EJ, Weilert F, Orr DW, et al. (2010) The mitochondriatargeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 30, 1019-1026.
19. Smith RA & Murphy MP (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 1201, 96-103.
20. Lim S, Rashid MA, Jang M, et al. (2011) Mitochondria-targeted antioxidants protect pancreatic beta-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol Biochem 28, 873-886.
21. Bour S, Carmona MC, Galinier A, et al. (2011) Coenzyme Q as an antiadipogenic factor. Antioxid Redox Signal 14, 403-413.
22. Feillet-Coudray C, Fouret G, Ebabe Elle R, et al. (2014) The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol. Free Radic Res 48, 1232-1246.
23. Aoun M, Fouret G, Michel F, et al. (2012) Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease. J Bioenerg Biomembr 44, 439-452.
24. Pu P, Gao DM, Mohamed S, et al. (2012) Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch Biochem Biophys 518, 61-70.
25. Aoun M, Feillet-Coudray C, Fouret G, et al. (2011) Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: effect of different nutritional lipid patterns. Br J Nutr 107, 647-659.
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
27. Baracca A, Sgarbi G, Solaini G, et al. (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta 1606, 137-146.
28. Capel F, Rimbert V, Lioger D, et al. (2005) Due to reverse electron transfer, mitochondrial H2O2 release increases with age in human vastus lateralis muscle although oxidative capacity is preserved. Mech Ageing Dev 126, 505-511.
29. Srere P (1969) Citrate synthase. Methods Enzymol 13, 3-11.
30. Teodoro JS, Rolo AP, Duarte FV, et al. (2008) Differential alterations in mitochondrial function induced by a cholinedeficient diet: understanding fatty liver disease progression. Mitochondrion 8, 367-376.
31. Djouadi F, Riveau B, Merlet-Benichou C, et al. (1997) Tissuespecific regulation of medium-chain acyl-CoA dehydrogenase gene by thyroid hormones in the developing rat. Biochem J 324, 289-294.
32. Clayton PT, Eaton S, Aynsley-Green A, et al. (2001) Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 108, 457-465.
33. Nulton-Persson AC & Szweda LI (2001) Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 276, 23357-23361.
34. Flamment M, Rieusset J, Vidal H, et al. (2012) Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats. J Physiol Biochem 68, 335-344.
35. Blachnio-Zabielska AU, Persson XM, Koutsari C, et al. (2012) A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom 26, 1134-1140.
36. Blachnio-Zabielska A, Zabielski P, Baranowski M, et al. (2011) Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity. Lipids 46, 229-238.
37. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234, 466-468.
38. Macala LJ, Yu RK & Ando S (1983) Analysis of brain lipids by high performance thin-layer chromatography and densitometry. J Lipid Res 24, 1243-1250.
39. Fink BD, Herlein JA, Guo DF, et al. (2014) A mitochondrialtargeted coenzyme q analog prevents weight gain and ameliorates hepatic dysfunction in high-fat-fed mice. J Pharmacol Exp Ther 351, 699-708.
40. Jiménez-Santos MA, Juarez-Rojop IE, Tovilla-Zarate CA, et al. (2014) Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet. Lipids Health Dis 13, 22.
41. van Herpen NA & Schrauwen-Hinderling VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94, 231-241.
42. Muoio DM (2010) Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim Biophys Acta 1801, 281-288.
43. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45, 42-72.
44. DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53, 1270-1287.
45. Blachnio-Zabielska A, Baranowski M, Zabielski P, et al. (2010) Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol 225, 786-791.
46. Bruce CR, Risis S, Babb JR, et al. (2012) Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 61, 3148-3155.
47. Jung HL & Kang HY (2010) Effects of endurance exercise and high-fat diet on insulin resistance and ceramide contents of skeletal muscle in Sprague-Dawley rats. Korean Diabetes J 34, 244-252.
48. Straczkowski M & Kowalska I (2008) The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud 5, 13-24.
49. Khavandgar Z & Murshed M (2015) Sphingolipid metabolism and its role in the skeletal tissues. Cell Mol Life Sci 72, 959-969.
50. Moussavi N, Gavino V & Receveur O (2008) Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring) 16, 7-15.
51. Poudyal H, Panchal SK, Diwan V, et al. (2011) Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 50, 372-387.
52. Pinel A, Morio-Liondore B & Capel F (2014) n-3 Polyunsaturated fatty acids modulate metabolism of insulinsensitive tissues: implication for the prevention of type 2 diabetes. J Physiol Biochem 70, 647-658.
53. Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851, 469-484.
54. Oh DY, Talukdar S, Bae EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
55. Holland WL, Knotts TA, Chavez JA, et al. (2007) Lipid mediators of insulin resistance. Nutr Rev 65, S39-S46.
56. Jude S, Martel E, Vincent F, et al. (2007) Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation. Br J Nutr 98, 1143-1151.
57. Lanza IR, Blachnio-Zabielska A, Johnson ML, et al. (2013) Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet. Am J Physiol Endocrinol Metab 304, E1391-E1403.